Horm Metab Res 2019; 51(01): 35-41
DOI: 10.1055/a-0798-3931
© Georg Thieme Verlag KG Stuttgart · New York

Metabolic Syndrome is a Risk Factor for Post-Operative Adhesions: Need for Novel Treatment Strategies

Yair Pilpel
1  EIO Biomedical Ltd, EIO Biomedical, Nazareth, Israel
Guy Pines
2  Department of Thoracic Surgery, Kaplan Medical Center, Affiliated to the Hebrew University School of Medicine, Rehovot, Israel
Andreas Birkenfeld
3  Universitätsklinikum Carl Gustav Carus, Medical Clinic III, Dresden, Germany
Stefan R. Bornstein
4  Department of Medicine, Universitätsklinikum Carl Gustav Carus, Dresden, Germany
Rafael Miller
5  Department of General Surgery, Kaplan Medical Center, Affiliated to Hebrew University Jerusalem, Rehovot, Israel
› Author Affiliations
Further Information

Publication History

received 16 July 2018

accepted 06 November 2018

Publication Date:
29 November 2018 (online)


Metabolic syndrome is a group of disorders which include obesity, diabetes, dyslipidemias, and hypertension. This condition is rapidly increasing in an aging population. The rates of surgery in older patients is also growing and a wide range of operations including minimally invasive procedures is now available for this segment of the population. The number of patients suffering from postoperative adhesions is therefore correspondingly increasing. In addition to preventing and treating the metabolic disease itself, improved therapeutic strategies for the prevention of surgical adhesions have to be developed. Here we review the existing and novel treatment options.